Your browser doesn't support javascript.
loading
Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization.
Bhatt, Ankeet S; Varshney, Anubodh S; Moscone, Alea; Claggett, Brian L; Miao, Zi Michael; Chatur, Safia; Lopes, Mathew S; Ostrominski, John W; Pabon, Maria A; Unlu, Ozan; Wang, Xiaowen; Bernier, Thomas D; Buckley, Leo F; Cook, Bryan; Eaton, Rachael; Fiene, Jillian; Kanaan, Dareen; Kelly, Julie; Knowles, Danielle M; Lupi, Kenneth; Matta, Lina S; Pimentel, Liriany Y; Rhoten, Megan N; Malloy, Rhynn; Ting, Clara; Chhor, Rosette; Guerin, Joshua R; Schissel, Scott L; Hoa, Brenda; Lio, Connie H; Milewski, Kristina; Espinosa, Michelle E; Liu, Zhenzhen; McHatton, Ralph; Cunningham, Jonathan W; Jering, Karola S; Bertot, John H; Kaur, Gurleen; Ahmad, Adeel; Akash, Muhammad; Davoudi, Farideh; Hinrichsen, Mona Z; Rabin, David L; Gordan, Patrick L; Roberts, David J; Urma, Daniela; McElrath, Erin E; Hinchey, Emily D; Choudhry, Niteesh K; Nekoui, Mahan.
Affiliation
  • Bhatt AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA; Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, California, USA.
  • Varshney AS; Division of Cardiovascular Medicine, Stanford University, Palo Alto, California, USA.
  • Moscone A; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Claggett BL; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Miao ZM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Chatur S; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Lopes MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Ostrominski JW; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Pabon MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Unlu O; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Wang X; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Bernier TD; Rush University Medical Center, Chicago, Illinois, USA.
  • Buckley LF; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Cook B; Mass General Brigham Center for Drug Policy, Boston, Massachusetts, USA.
  • Eaton R; Department of Pharmacy, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Fiene J; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Kanaan D; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Kelly J; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Knowles DM; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lupi K; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Matta LS; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Pimentel LY; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Rhoten MN; Department of Pharmacy Services, Carilion Roanoke Memorial Hospital, Roanoke, Virginia, USA.
  • Malloy R; Department of Pharmacy, Children's Hospital Colorado, Denver, Colorado, USA.
  • Ting C; University of Chicago Medical Center, Chicago, Illinois, USA.
  • Chhor R; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Guerin JR; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Schissel SL; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Hoa B; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Lio CH; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Milewski K; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Espinosa ME; Brigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
  • Liu Z; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • McHatton R; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Cunningham JW; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Jering KS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Bertot JH; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Kaur G; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Ahmad A; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Akash M; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Davoudi F; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Hinrichsen MZ; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Rabin DL; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Gordan PL; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Roberts DJ; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • Urma D; Salem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
  • McElrath EE; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Hinchey ED; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Choudhry NK; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Nekoui M; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Am Coll Cardiol ; 81(17): 1680-1693, 2023 05 02.
Article de En | MEDLINE | ID: mdl-36889612
ABSTRACT

BACKGROUND:

Scalable and safe approaches for heart failure guideline-directed medical therapy (GDMT) optimization are needed.

OBJECTIVES:

The authors assessed the safety and effectiveness of a virtual care team guided strategy on GDMT optimization in hospitalized patients with heart failure with reduced ejection fraction (HFrEF).

METHODS:

In a multicenter implementation trial, we allocated 252 hospital encounters in patients with left ventricular ejection fraction ≤40% to a virtual care team guided strategy (107 encounters among 83 patients) or usual care (145 encounters among 115 patients) across 3 centers in an integrated health system. In the virtual care team group, clinicians received up to 1 daily GDMT optimization suggestion from a physician-pharmacist team. The primary effectiveness outcome was in-hospital change in GDMT optimization score (+2 initiations, +1 dose up-titrations, -1 dose down-titrations, -2 discontinuations summed across classes). In-hospital safety outcomes were adjudicated by an independent clinical events committee.

RESULTS:

Among 252 encounters, the mean age was 69 ± 14 years, 85 (34%) were women, 35 (14%) were Black, and 43 (17%) were Hispanic. The virtual care team strategy significantly improved GDMT optimization scores vs usual care (adjusted difference +1.2; 95% CI 0.7-1.8; P < 0.001). New initiations (44% vs 23%; absolute difference +21%; P = 0.001) and net intensifications (44% vs 24%; absolute difference +20%; P = 0.002) during hospitalization were higher in the virtual care team group, translating to a number needed to intervene of 5 encounters. Overall, 23 (21%) in the virtual care team group and 40 (28%) in usual care experienced 1 or more adverse events (P = 0.30). Acute kidney injury, bradycardia, hypotension, hyperkalemia, and hospital length of stay were similar between groups.

CONCLUSIONS:

Among patients hospitalized with HFrEF, a virtual care team guided strategy for GDMT optimization was safe and improved GDMT across multiple hospitals in an integrated health system. Virtual teams represent a centralized and scalable approach to optimize GDMT.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Défaillance cardiaque Type d'étude: Clinical_trials / Guideline Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: J Am Coll Cardiol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Défaillance cardiaque Type d'étude: Clinical_trials / Guideline Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: J Am Coll Cardiol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...